Ionis Pharmaceuticals

Discovers and develops RNA-targeted medicines for serious diseases.

Founded 1989 · 1,402 employees · United States · Public

Listed:

NASDAQ: IONS

Subsidiaries:

Akcea Therapeutics, Ionis USA Limited, Osprey Therapeutics